TreeWAS – Variant ID: rs12501032

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C18.2 Ascending colon	0.018	0.982	0.000
C18.3 Hepatic flexure	0.016	0.984	0.000
C18 Malignant neoplasm of colon	0.015	0.985	0.000
C18.4 Transverse colon	0.014	0.986	0.000
N81.9 Female genital prolapse, unspecified	0.012	0.988	0.000
Z00.6 Examination for normal comparison and control in clinical research programme	0.012	0.988	0.000
C18.8 Overlapping lesion of colon	0.012	0.988	0.000
C18.5 Splenic flexure	0.011	0.989	0.000
O30.0 Twin pregnancy	0.010	0.990	0.000
C18.6 Descending colon	0.010	0.990	0.000
C77.0 Lymph nodes of head, face and neck	0.009	0.991	0.000
C18.1 Appendix	0.009	0.991	0.000
C18.7 Sigmoid colon	0.009	0.991	0.000
L60.0 Ingrowing nail	0.008	0.992	0.000
T93.2 Sequelae of other fractures of lower limb	0.008	0.992	0.000
C22.0 Liver cell carcinoma	0.007	0.993	0.000
Z00.0 General medical examination	0.007	0.993	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.007	0.993	0.000
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.007	0.993	0.000
C15-C26 Malignant neoplasms of digestive organs	0.007	0.993	0.000
B18.2 Chronic viral hepatitis C	0.000	0.993	0.007
M95.0 Acquired deformity of nose	0.000	0.994	0.006
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.006	0.994	0.000
C16 Malignant neoplasm of stomach	0.006	0.994	0.000
C18.9 Colon, unspecified	0.006	0.994	0.000
C81.9 Hodgkin's disease, unspecified	0.006	0.994	0.000
C24.0 Extrahepatic bile duct	0.006	0.994	0.000
C21 Malignant neoplasm of anus and anal canal	0.005	0.994	0.000
C16.0 Cardia	0.005	0.995	0.000
C90.0 Multiple myeloma	0.005	0.995	0.000
Z00.8 Other general examinations	0.005	0.995	0.000
C81 Hodgkin's disease	0.005	0.995	0.000
C22.7 Other specified carcinomas of liver	0.005	0.995	0.000
C22.4 Other sarcomas of liver	0.005	0.995	0.000
C22.3 Angiosarcoma of liver	0.005	0.995	0.000
C22.2 Hepatoblastoma	0.005	0.995	0.000
C81.1 Nodular sclerosis	0.005	0.995	0.000
Z00.3 Examination for adolescent development state	0.005	0.995	0.000
Z00.2 Examination for period of rapid growth in childhood	0.005	0.995	0.000
Z00.1 Routine child health examination	0.005	0.995	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.005	0.995	0.000
C16.2 Body of stomach	0.005	0.995	0.000
C81.7 Other Hodgkin's disease	0.005	0.995	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.005	0.995	0.000
C22.1 Intrahepatic bile duct carcinoma	0.005	0.995	0.000
C16.3 Pyloric antrum	0.005	0.995	0.000
C22.9 Liver, unspecified	0.005	0.995	0.000
H61.2 Impacted cerumen	0.000	0.995	0.005
C24.9 Biliary tract, unspecified	0.005	0.995	0.000
C16.1 Fundus of stomach	0.005	0.995	0.000
C32.0 Glottis	0.005	0.995	0.000
T14.0 Superficial injury of unspecified body region	0.005	0.995	0.000
Z00.4 General psychiatric examination, not elsewhere classified	0.005	0.995	0.000
C24.1 Ampulla of Vater	0.005	0.995	0.000
C24.8 Overlapping lesion of biliary tract	0.005	0.995	0.000
C32 Malignant neoplasm of larynx	0.005	0.995	0.000
C23 Malignant neoplasm of gallbladder	0.005	0.995	0.000
C16.9 Stomach, unspecified	0.005	0.995	0.000
C16.8 Overlapping lesion of stomach	0.005	0.995	0.000
C16.4 Pylorus	0.005	0.995	0.000
K22.4 Dyskinesia of oesophagus	0.005	0.995	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.004	0.995	0.000
C21.0 Anus, unspecified	0.004	0.995	0.000
C32.9 Larynx, unspecified	0.004	0.996	0.000
O30 Multiple gestation	0.004	0.996	0.000
C50.9 Breast, unspecified	0.004	0.996	0.000
C16.5 Lesser curvature of stomach, unspecified	0.004	0.996	0.000
C26.0 Intestinal tract, part unspecified	0.004	0.996	0.000
C21.2 Cloacogenic zone	0.004	0.996	0.000
C32.1 Supraglottis	0.004	0.996	0.000
C16.6 Greater curvature of stomach, unspecified	0.004	0.996	0.000
B18 Chronic viral hepatitis	0.000	0.996	0.004
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.004	0.996	0.000
C81.3 Lymphocytic depletion	0.004	0.996	0.000
C26.8 Overlapping lesion of digestive system	0.004	0.996	0.000
C26.1 Spleen	0.004	0.996	0.000
C17 Malignant neoplasm of small intestine	0.004	0.996	0.000
C06.2 Retromolar area	0.004	0.996	0.000
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.000	0.996	0.004
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.004	0.996	0.000
C32.8 Overlapping lesion of larynx	0.004	0.996	0.000
C32.3 Laryngeal cartilage	0.004	0.996	0.000
C32.2 Subglottis	0.004	0.996	0.000
C21.1 Anal canal	0.004	0.996	0.000
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.996	0.004
C81.2 Mixed cellularity	0.003	0.996	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.004	0.996	0.000
Q89 Other congenital malformations, not elsewhere classified	0.004	0.996	0.000
C26.9 Ill-defined sites within the digestive system	0.003	0.996	0.000
Q89.2 Congenital malformations of other endocrine glands	0.004	0.996	0.000
Q83 Congenital malformations of breast	0.004	0.996	0.000
Q82.8 Other specified congenital malformations of skin	0.004	0.996	0.000
Q83.8 Other congenital malformations of breast	0.004	0.996	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.004	0.996	0.000
Z00.5 Examination of potential donor of organ and tissue	0.003	0.996	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.003	0.996	0.000
C25 Malignant neoplasm of pancreas	0.003	0.996	0.000
Q80-Q89 Other congenital malformations	0.004	0.996	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
Q82 Other congenital malformations of skin	0.003	0.997	0.000
O30.9 Multiple gestation, unspecified	0.003	0.997	0.000
O30.8 Other multiple gestation	0.003	0.997	0.000
O30.2 Quadruplet pregnancy	0.003	0.997	0.000
O30.1 Triplet pregnancy	0.003	0.997	0.000
C34.1 Upper lobe, bronchus or lung	0.003	0.997	0.000
C38.4 Pleura	0.003	0.997	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.003	0.997	0.000
C05 Malignant neoplasm of palate	0.003	0.997	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.003	0.997	0.000
M95.4 Acquired deformity of chest and rib	0.000	0.997	0.003
C05.9 Palate, unspecified	0.003	0.997	0.000
C25.1 Body of pancreas	0.003	0.997	0.000
Q85 Phakomatoses, not elsewhere classified	0.003	0.997	0.000
E53.8 Deficiency of other specified B group vitamins	0.000	0.997	0.003
C37 Malignant neoplasm of thymus	0.003	0.997	0.000
K60.1 Chronic anal fissure	0.000	0.997	0.003
C81.0 Lymphocytic predominance	0.003	0.997	0.000
B18.9 Chronic viral hepatitis, unspecified	0.000	0.997	0.003
B18.8 Other chronic viral hepatitis	0.000	0.997	0.003
B18.0 Chronic viral hepatitis B with delta-agent	0.000	0.997	0.003
Q82.0 Hereditary lymphoedema	0.003	0.997	0.000
Q89.3 Situs inversus	0.003	0.997	0.000
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.003	0.997	0.000
C30.0 Nasal cavity	0.003	0.997	0.000
C06.0 Cheek mucosa	0.003	0.997	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.003	0.997	0.000
C07 Malignant neoplasm of parotid gland	0.003	0.997	0.000
Q83.1 Accessory breast	0.003	0.997	0.000
M95.3 Acquired deformity of neck	0.000	0.997	0.003
C31 Malignant neoplasm of accessory sinuses	0.003	0.997	0.000
C17.8 Overlapping lesion of small intestine	0.003	0.997	0.000
C17.3 Meckel's diverticulum	0.003	0.997	0.000
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.000	0.997	0.003
M95.8 Other specified acquired deformities of musculoskeletal system	0.000	0.997	0.003
M95.5 Acquired deformity of pelvis	0.000	0.997	0.003
M95.2 Other acquired deformity of head	0.000	0.997	0.003
M95.1 Cauliflower ear	0.000	0.997	0.003
C11 Malignant neoplasm of nasopharynx	0.003	0.997	0.000
Q83.3 Accessory nipple	0.003	0.997	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.003	0.997	0.000
C33 Malignant neoplasm of trachea	0.003	0.997	0.000
C17.9 Small intestine, unspecified	0.003	0.997	0.000
Q85.9 Phakomatosis, unspecified	0.003	0.997	0.000
C25.2 Tail of pancreas	0.003	0.997	0.000
C08.9 Major salivary gland, unspecified	0.003	0.997	0.000
C12 Malignant neoplasm of pyriform sinus	0.003	0.997	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.003	0.997	0.000
C06.1 Vestibule of mouth	0.003	0.997	0.000
C25.3 Pancreatic duct	0.003	0.997	0.000
Q89.9 Congenital malformation, unspecified	0.003	0.997	0.000
Q89.8 Other specified congenital malformations	0.003	0.997	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.003	0.997	0.000
Q89.4 Conjoined twins	0.003	0.997	0.000
Q89.1 Congenital malformations of adrenal gland	0.003	0.997	0.000
Q89.0 Congenital malformations of spleen	0.003	0.997	0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation	0.000	0.997	0.003
Q83.9 Congenital malformation of breast, unspecified	0.003	0.997	0.000
Q83.2 Absent nipple	0.003	0.997	0.000
Q83.0 Congenital absence of breast with absent nipple	0.003	0.997	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.003	0.997	0.000
C05.1 Soft palate	0.003	0.997	0.000
Z37.2 Twins, both liveborn	0.003	0.997	0.000
C06.9 Mouth, unspecified	0.003	0.997	0.000
F45.8 Other somatoform disorders	0.000	0.997	0.003
I49.5 Sick sinus syndrome	0.000	0.997	0.003
Q85.8 Other phakomatoses, not elsewhere classified	0.003	0.997	0.000
C17.0 Duodenum	0.003	0.997	0.000
C25.7 Other parts of pancreas	0.003	0.997	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.003	0.997	0.000
C38.3 Mediastinum, part unspecified	0.003	0.997	0.000
C38.2 Posterior mediastinum	0.003	0.997	0.000
C38.1 Anterior mediastinum	0.003	0.997	0.000
C38.0 Heart	0.003	0.997	0.000
C90.3 Solitary plasmacytoma	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C25.8 Overlapping lesion of pancreas	0.003	0.997	0.000
C25.4 Endocrine pancreas	0.003	0.997	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.003	0.997	0.000
Q84 Other congenital malformations of integument	0.003	0.997	0.000
Q81 Epidermolysis bullosa	0.003	0.997	0.000
Q80 Congenital ichthyosis	0.003	0.997	0.000
N13.3 Other and unspecified hydronephrosis	0.000	0.997	0.003
C03 Malignant neoplasm of gum	0.003	0.997	0.000
C00 Malignant neoplasm of lip	0.003	0.997	0.000
D10.3 Other and unspecified parts of mouth	0.003	0.997	0.000
Q82.9 Congenital malformation of skin, unspecified	0.003	0.997	0.000
Q82.4 Ectodermal dysplasia (anhidrotic)	0.003	0.997	0.000
Q82.3 Incontinentia pigmenti	0.003	0.997	0.000
Q82.1 Xeroderma pigmentosum	0.003	0.997	0.000
W05.0 Home	0.003	0.997	0.000
C95 Leukaemia of unspecified cell type	0.003	0.997	0.000
C05.8 Overlapping lesion of palate	0.003	0.997	0.000
C05.2 Uvula	0.003	0.997	0.000
C05.0 Hard palate	0.003	0.997	0.000
C30.1 Middle ear	0.003	0.997	0.000
C13 Malignant neoplasm of hypopharynx	0.003	0.997	0.000
C17.1 Jejunum	0.002	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.003	0.997	0.000
Q85.1 Tuberous sclerosis	0.003	0.997	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
C11.1 Posterior wall of nasopharynx	0.002	0.997	0.000
N21.0 Calculus in bladder	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
S92.00 Fracture of calcaneus (closed)	0.003	0.997	0.000
C11.9 Nasopharynx, unspecified	0.002	0.997	0.000
C95.9 Leukaemia, unspecified	0.002	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.997	0.003
C71.9 Brain, unspecified	0.003	0.997	0.000
I35.8 Other aortic valve disorders	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.003	0.997	0.000
C71 Malignant neoplasm of brain	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.997	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.003	0.997	0.000
C20 Malignant neoplasm of rectum	0.003	0.997	0.000
E87.5 Hyperkalaemia	0.000	0.997	0.003
C01 Malignant neoplasm of base of tongue	0.002	0.997	0.000
C08.8 Overlapping lesion of major salivary glands	0.002	0.997	0.000
C08.1 Sublingual gland	0.002	0.997	0.000
C31.0 Maxillary sinus	0.002	0.997	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.002	0.998	0.000
C17.2 Ileum	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
C31.9 Accessory sinus, unspecified	0.002	0.998	0.000
C31.8 Overlapping lesion of accessory sinuses	0.002	0.998	0.000
C31.3 Sphenoidal sinus	0.002	0.998	0.000
C31.2 Frontal sinus	0.002	0.998	0.000
C31.1 Ethmoidal sinus	0.002	0.998	0.000
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
M95.96 Acquired deformity of musculoskeletal system, unspecified	0.000	0.998	0.002
C11.8 Overlapping lesion of nasopharynx	0.002	0.998	0.000
C11.3 Anterior wall of nasopharynx	0.002	0.998	0.000
C11.2 Lateral wall of nasopharynx	0.002	0.998	0.000
C11.0 Superior wall of nasopharynx	0.002	0.998	0.000
C08.0 Submandibular gland	0.002	0.998	0.000
C39.9 Ill-defined sites within the respiratory system	0.002	0.998	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.002	0.998	0.000
C39.0 Upper respiratory tract, part unspecified	0.002	0.998	0.000
K00.6 Disturbances in tooth eruption	0.002	0.998	0.000
C04 Malignant neoplasm of floor of mouth	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
L60.9 Nail disorder, unspecified	0.002	0.998	0.000
C10 Malignant neoplasm of oropharynx	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
Q82.2 Mastocytosis	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.000	0.998	0.002
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
Q82.5 Congenital nonneoplastic naevus	0.002	0.998	0.000
L60 Nail disorders	0.002	0.998	0.000
C00.0 External upper lip	0.002	0.998	0.000
C03.1 Lower gum	0.002	0.998	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.998	0.002
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.002	0.998	0.000
T14 Injury of unspecified body region	0.002	0.998	0.000
Q80.9 Congenital ichthyosis, unspecified	0.002	0.998	0.000
Q80.8 Other congenital ichthyosis	0.002	0.998	0.000
Q80.4 Harlequin foetus	0.002	0.998	0.000
Q80.3 Congenital bullous ichthyosiform erythroderma	0.002	0.998	0.000
Q80.2 Lamellar ichthyosis	0.002	0.998	0.000
Q80.1 X-linked ichthyosis	0.002	0.998	0.000
Q80.0 Ichthyosis vulgaris	0.002	0.998	0.000
Q81.9 Epidermolysis bullosa, unspecified	0.002	0.998	0.000
Q81.8 Other epidermolysis bullosa	0.002	0.998	0.000
Q81.2 Epidermolysis bullosa dystrophica	0.002	0.998	0.000
Q81.1 Epidermolysis bullosa letalis	0.002	0.998	0.000
Q81.0 Epidermolysis bullosa simplex	0.002	0.998	0.000
Q84.9 Congenital malformation of integument, unspecified	0.002	0.998	0.000
Q84.8 Other specified congenital malformations of integument	0.002	0.998	0.000
Q84.6 Other congenital malformations of nails	0.002	0.998	0.000
Q84.5 Enlarged and hypertrophic nails	0.002	0.998	0.000
Q84.4 Congenital leukonychia	0.002	0.998	0.000
Q84.3 Anonychia	0.002	0.998	0.000
Q84.2 Other congenital malformations of hair	0.002	0.998	0.000
Q84.1 Congenital morphological disturbances of hair, not elsewhere classified	0.002	0.998	0.000
Q84.0 Congenital alopecia	0.002	0.998	0.000
Q86.8 Other congenital malformation syndromes due to known exogenous causes	0.002	0.998	0.000
Q86.2 Dysmorphism due to warfarin	0.002	0.998	0.000
Q86.1 Foetal hydantoin syndrome	0.002	0.998	0.000
Q86.0 Foetal alcohol syndrome (dysmorphic)	0.002	0.998	0.000
C09 Malignant neoplasm of tonsil	0.002	0.998	0.000
C00.9 Lip, unspecified	0.002	0.998	0.000
C00.8 Overlapping lesion of lip	0.002	0.998	0.000
C00.6 Commissure of lip	0.002	0.998	0.000
C00.5 Lip, unspecified, inner aspect	0.002	0.998	0.000
C00.4 Lower lip, inner aspect	0.002	0.998	0.000
C00.3 Upper lip, inner aspect	0.002	0.998	0.000
C00.2 External lip, unspecified	0.002	0.998	0.000
C00.1 External lower lip	0.002	0.998	0.000
C03.9 Gum, unspecified	0.002	0.998	0.000
C03.0 Upper gum	0.002	0.998	0.000
C13.9 Hypopharynx, unspecified	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.002	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.998	0.000
C13.8 Overlapping lesion of hypopharynx	0.002	0.998	0.000
C13.2 Posterior wall of hypopharynx	0.002	0.998	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.002	0.998	0.000
C14.2 Waldeyer's ring	0.002	0.998	0.000
Z39.2 Routine postpartum follow-up	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
C02.4 Lingual tonsil	0.002	0.998	0.000
C13.0 Postcricoid region	0.002	0.998	0.000
C14.0 Pharynx, unspecified	0.002	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.002	0.998	0.000
G93.6 Cerebral oedema	0.002	0.998	0.000
W05.9 Unspecified place	0.002	0.998	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.998	0.002
C02.8 Overlapping lesion of tongue	0.002	0.998	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.002	0.998	0.000
C02.0 Dorsal surface of tongue	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
L60.1 Onycholysis	0.002	0.998	0.000
C34 Malignant neoplasm of bronchus and lung	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
M23.49 Loose body in knee-Unspec lig/men	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.998	0.002
C02.2 Ventral surface of tongue	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.002	0.998	0.000
C04.8 Overlapping lesion of floor of mouth	0.002	0.998	0.000
C04.1 Lateral floor of mouth	0.002	0.998	0.000
C04.0 Anterior floor of mouth	0.002	0.998	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.002	0.998	0.000
I31.9 Disease of pericardium, unspecified	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
C02.9 Tongue, unspecified	0.002	0.998	0.000
C10.8 Overlapping lesion of oropharynx	0.002	0.998	0.000
C10.4 Branchial cleft	0.002	0.998	0.000
C10.3 Posterior wall of oropharynx	0.002	0.998	0.000
C10.2 Lateral wall of oropharynx	0.002	0.998	0.000
C10.1 Anterior surface of epiglottis	0.002	0.998	0.000
C10.0 Vallecula	0.002	0.998	0.000
C41.0 Bones of skull and face	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.002	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.002	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.002	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.002	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.002	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.002	0.998	0.000
Z90.2 Acquired absence of lung [part of]	0.002	0.998	0.000
E53 Deficiency of other B group vitamins	0.000	0.998	0.002
C71.3 Parietal lobe	0.002	0.998	0.000
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.002
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.002
C85.0 Lymphosarcoma	0.002	0.998	0.000
L60.5 Yellow nail syndrome	0.002	0.998	0.000
L60.4 Beau's lines	0.002	0.998	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
C71.1 Frontal lobe	0.002	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
C94.7 Other specified leukaemias	0.002	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.998	0.000
C94.5 Acute myelofibrosis	0.002	0.998	0.000
C94.4 Acute panmyelosis	0.002	0.998	0.000
C94.3 Mast cell leukaemia	0.002	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.998	0.000
C94.1 Chronic erythraemia	0.002	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.998	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
C96.8 Histiocytic sarcoma	0.002	0.998	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.998	0.000
C96.3 True histiocytic lymphoma	0.002	0.998	0.000
C96.2 Malignant mast cell tumour	0.002	0.998	0.000
C96.1 Malignant histiocytosis	0.002	0.998	0.000
C96.0 Letterer-Siwe disease	0.002	0.998	0.000
Q87.5 Other congenital malformation syndromes with other skeletal changes	0.002	0.998	0.000
Q87.3 Congenital malformation syndromes involving early overgrowth	0.002	0.998	0.000
Q87.2 Congenital malformation syndromes predominantly involving limbs	0.002	0.998	0.000
Q87.1 Congenital malformation syndromes predominantly associated with short stature	0.002	0.998	0.000
T14.2 Fracture of unspecified body region	0.002	0.998	0.000
T14.8 Other injuries of unspecified body region	0.002	0.998	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.002	0.998	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.002	0.998	0.000
T14.4 Injury of nerve(s) of unspecified body region	0.002	0.998	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.002	0.998	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.002	0.998	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.002
C09.8 Overlapping lesion of tonsil	0.002	0.998	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.002	0.998	0.000
C09.0 Tonsillar fossa	0.002	0.998	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.002	0.998	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.998	0.002
C15 Malignant neoplasm of oesophagus	0.002	0.998	0.000
C41.9 Bone and articular cartilage, unspecified	0.002	0.998	0.000
C77.5 Intrapelvic lymph nodes	0.002	0.998	0.000
G93.0 Cerebral cysts	0.002	0.998	0.000
T14.6 Injury of tendons and muscles of unspecified body region	0.002	0.998	0.000
F45.0 Somatisation disorder	0.000	0.998	0.002
Q87.8 Other specified congenital malformation syndromes, not elsewhere classified	0.002	0.998	0.000
W05 Fall involving wheelchair	0.002	0.998	0.000
C02.1 Border of tongue	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.002	0.998	0.000
C91.7 Other lymphoid leukaemia	0.002	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.002	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.002	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.002	0.998	0.000
T88.8 Other specified complications of surgical and medical care, not elsewhere classified	0.002	0.998	0.000
E53.9 Vitamin B deficiency, unspecified	0.000	0.998	0.002
C41.1 Mandible	0.002	0.998	0.000
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance	0.002	0.998	0.000
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered	0.002	0.998	0.000
F45 Somatoform disorders	0.000	0.998	0.002
C34.8 Overlapping lesion of bronchus and lung	0.002	0.998	0.000
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
Z39.1 Care and examination of lactating mother	0.000	0.998	0.002
C40-C41 Malignant neoplasms of bone and articular cartilage	0.002	0.998	0.000
C41.4 Pelvic bones, sacrum and coccyx	0.002	0.998	0.000
G47.9 Sleep disorder, unspecified	0.000	0.998	0.002
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.002	0.998	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.998	0.000
C93.7 Other monocytic leukaemia	0.002	0.998	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.998	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.998	0.000
C93.0 Acute monocytic leukaemia	0.002	0.998	0.000
N41.0 Acute prostatitis	0.000	0.998	0.002
T14.9 Injury, unspecified	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.998	0.000
C88.2 Gamma heavy chain disease	0.002	0.998	0.000
C88.1 Alpha heavy chain disease	0.002	0.998	0.000
T91.9 Sequelae of unspecified injury of neck and trunk	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
Y00.9 Unspecified place	0.000	0.998	0.002
C41.8 Overlapping lesion of bone and articular cartilage	0.002	0.998	0.000
C41.3 Ribs, sternum and clavicle	0.002	0.998	0.000
C41.2 Vertebral column	0.002	0.998	0.000
T14.1 Open wound of unspecified body region	0.002	0.998	0.000
C04.9 Floor of mouth, unspecified	0.001	0.998	0.000
I27 Other pulmonary heart diseases	0.000	0.998	0.002
Chapter II Neoplasms	0.002	0.998	0.000
A40.9 Streptococcal septicaemia, unspecified	0.000	0.998	0.002
C15.4 Middle third of oesophagus	0.002	0.998	0.000
E53.1 Pyridoxine deficiency	0.000	0.998	0.002
E53.0 Riboflavin deficiency	0.000	0.998	0.002
H26.4 After-cataract	0.002	0.998	0.000
C10.9 Oropharynx, unspecified	0.001	0.998	0.000
D10.0 Lip	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.002	0.998	0.000
F45.9 Somatoform disorder, unspecified	0.000	0.998	0.002
R49.0 Dysphonia	0.002	0.998	0.000
T14.21 Fracture of unspecified body region (open)	0.001	0.998	0.000
T14.20 Fracture of unspecified body region (closed)	0.001	0.998	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.998	0.002
C70 Malignant neoplasm of meninges	0.002	0.998	0.000
C15.8 Overlapping lesion of oesophagus	0.001	0.998	0.000
C15.2 Abdominal part of oesophagus	0.001	0.998	0.000
C15.0 Cervical part of oesophagus	0.001	0.998	0.000
F45.4 Persistent somatoform pain disorder	0.000	0.998	0.002
L60.2 Onychogryphosis	0.001	0.998	0.000
C15.1 Thoracic part of oesophagus	0.001	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.002	0.998	0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
W05.8 Other specified place	0.001	0.998	0.000
W05.7 Farm	0.001	0.998	0.000
W05.6 Industrial and construction area	0.001	0.998	0.000
W05.5 Trade and service area	0.001	0.998	0.000
W05.4 Street and highway	0.001	0.998	0.000
W05.3 Sports and athletics area	0.001	0.998	0.000
W05.2 School, other institution and public administrative area	0.001	0.998	0.000
W05.1 Residential institution	0.001	0.998	0.000
Y00.0 Home	0.000	0.998	0.002
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)	0.002	0.998	0.000
C78.2 Secondary malignant neoplasm of pleura	0.002	0.998	0.000
F45.2 Hypochondriacal disorder	0.000	0.998	0.001
F45.1 Undifferentiated somatoform disorder	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations